The table below shows Coherus BioSciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$57.89M
-$25.83M
-$46.77M
-$68.73M
-$54.05M
$1.37M
Capital expenditure
-
-
-
$152.00K
$615.00K
$145.00K
Investing cash flow
$30.66M
-$17.49M
$202.76M
$17.53M
-$35.62M
-$285.48M
Dividends paid
-
-
-
-
CHRS operating cash flow (10-K history)
Coherus BioSciences, Inc. reported operating cash flow of -$138.51M for fiscal year 2025. That is down 577.7% from -$20.44M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$252.54M (FY 2016) to -$138.51M. Figures come from the company's audited annual reports as filed with the SEC.